HPR Dr. Schaffler GmbH https://validator.w3.org/feed/docs/rss2.html PUBLICATIONS Invited Speech at NIH Pain Workshop Washington DC Nov 15th 2018 (Video Cast) Human Pharmaco Research COMPANY Study Step-by-step SERVICE APPROACH A Phase I, randomized, double-blind, laser evoked potential study to evaluate the analgesic/anti-hyperalgesic effect of ASP9226, a state-dependent N-type voltage-gated calcium channel inhibitor, in healthy male subjects HPR Dr. Schaffler GmbH führt klinische Studie Phase 1B an Z944 in Zusammenarbeit mit Zalicus durch… HPR’s research on topical compound by Alzecure Pharma – presented June 9-11 and June 16-18 at IASP 2021 World Congress on Pain HPR Poster Präsentation und Konferenzteilnahme am 15. IASP Schmerzkongress in Buenos Aires 2014 HPR Dr. Schaffler GmbH Corporate Video… Important invitation by NIH to participate in “Discovery of Biomarkers to Develop Transformational Non-Addictive Therapeutics for Pain” HPR – Human Pharmacodynamics Privacy Policy Datenschutzerklärung Legal notice Kontakt Services_old Trial Participants/Volunteers Algesimetry Unternehmen CONTACT HPR Dr. Schaffler GmbH in cooperation with Zalicus announces positive results of Z944 Phase 1B Clinical Study in Pain Contact_old 7th Congress of the European Federation of IASP Chapters (EFIC) – PAIN IN EUROPE VII – Hamburg, Germany, September 2011 Studienteilnehmer/Probanden 13th World Congress on Pain (IASP) in Montreal, Quebec, Canada, Aug./Sept. 2010 Dose-response relationship after single oral dose administrations of morphine and oxycodone using laser-evoked potentials on UVB- and capsaicin-irritated skin in healthy male subjects HPR Poster Presentation at the 15th World Congress on Pain in Buenos Aires 2014 A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase I Study of Analgesic/Antihyperalgesic Properties of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Healthy Female Subjects Nützliche Links Bewegungskrankheit (Motion Sickness): Induktion and Beeinflussung Skeletto-motorische Funktionsmessung: Tremor Skeletto-motorische Funktionsmessung: Dynamometrie Nebenwirkungsmessung ZNS-wirksamer Substanzen Human PD-Methods in Detail Substanz-Alkohol Interaktionen Selected Publications & Presentations (Pain only) Publications & Presentations (CNS & Pain) Phase-I Pilot Study: Investigating objective measures of pain-processing-related nociception and subjective pain perception in an elderly cohort in the presence and absence of a standard analgesic on irritated (UVB) and non-irritated skin American Society for Clinical Pharmacology and Therapeutics 2012 ASCPT Annual Meeting, March 12-17, 2012 in National Harbor, Maryland, US Investigation of the predictive validity of laser- EPs in normal, UVB-inflamed and capsaicin-irritated skin with four analgesic compounds in healthy volunteers Hypoxie: Zerebrale Defizitinduktion (Demenzsimulation) Publikationen im Bereich ZNS & Schmerz PD-Methoden am Menschen im Detail An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B)-inflamed and normal skin Unsere Leistungen Motion sickness: induction and treatment Publikationen im Bereich Schmerz